Diaceutics PLC (FRA:7DC)
€ 1.38 -0.05 (-3.5%) Market Cap: 119.03 Mil Enterprise Value: 100.30 Mil PE Ratio: 0 PB Ratio: 2.69 GF Score: 86/100

Diaceutics PLC Capital Markets Day Transcript

Jun 16, 2021 / 12:00PM GMT
Release Date Price: €1.44 (+0.70%)
Deborah Lee Davis
Diaceutics PLC - Non-Executive Chair

Hello, everyone, and welcome to Diaceutics Capital Markets Day. My name is Deborah Davis. I'm non-Executive Chair of Diaceutics.

In the next couple of hours, we're looking forward to sharing with you the opportunities that we see at Diaceutics and our DXRX platform to play a pivotal role in the rapidly growing industry of precision medicine.

In the next couple of hours, we will cover a number of things. I'm joined today by 4 members of our Board and Executive team. Peter Keeling, Ryan Keeling, Susanne Munksted and Philip White.

Our agenda for today will start with Peter providing an overview of Diaceutics and the precision medicine diagnostic landscape. He will be followed by Ryan, who will take us through a series of demonstrations of DXRX capability. We're delighted to be joined by 3 experts from the diagnostics and precision medicine world and Susanne will introduce our special guests when she facilitates the panel discussion, before opening the floor to questions.

If you do have questions on the DXRX

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot